Inflammation plays a pivotal role in the pathogenesis of stroke (3, 19), with key mediators —specifically IL-1β (neutrophil recruitment), IL-6 (acute-phase amplification), and TNF-α (neuronal apoptosis)— confirmed to drive secondary injury and correlate with ICH severity/prognosis (19, 20). Here, IL1B is linked to stroke disorder.